Skip to main content
OpenTrials

Clinical trial condition

Hodgkin Disease

Explore clinical trials studying Hodgkin Disease. Study availability and eligibility vary by location and protocol.

958 public trials 99 recruiting studies
Refine in advanced search Browse all conditions

Hodgkin Disease trial results

Completed

A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years

NCT00079105

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations
  • Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany
  • Wansbeck General Hospital Ashington, England, United Kingdom
  • Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom
  • Royal United Hospital Bath, England, United Kingdom
View all 54 locations
View Trial Details
Completed

A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma

NCT00848926

Conditions
Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
View all 27 locations
View Trial Details
Completed

Tandem Auto-Allo Transplant for Lymphoma

NCT01181271

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse, Large B-Cell, Lymphoma, +27 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

NCT00755040

Conditions
Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +62 more
Locations
  • Stanford University Palo Alto, California, United States
  • Norwestern Memorial Hospital Chicago, Illinois, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • M. D. Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease

NCT00002495

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations
  • University of California San Diego Cancer Center La Jolla, California, United States
  • CCOP - Christiana Care Health Services Wilmington, Delaware, United States
  • Walter Reed Army Medical Center Washington D.C., District of Columbia, United States
  • CCOP - Mount Sinai Medical Center Miami Beach, Florida, United States
View all 22 locations
View Trial Details

Related conditions